Cardioprotective effect of resveratrol via HO-1 expression involves p38 map kinase and PI-3-kinase signaling, but does not involve NFκB

Free Radical Research

Volumn 40, Issue 10, 2006, Pages 1066-1075

  Das, Samarjit ^a   Fraga, Cesar G ^b,c   Das, Dipak K ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Akt; Heme oxygenase; NF B; p38 MAP kinase; Resveratrol

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTOPORPHYRIN TIN; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEEDING; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CARDIOTONIC AGENTS; HEART; HEME OXYGENASE-1; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; METALLOPORPHYRINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTOPORPHYRINS; RATS; SIGNAL TRANSDUCTION; STILBENES;

VITACEAE;

EID: 33749265695     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760600833085     Document Type: Conference Paper

References (49)

1. Creasy, LL and Coffee, M. (1988) Phytoalexin production potential of grape berries J Am Soc Hortic Sci, 113, pp. 230-234.
2. Paul, B and Masih, I and Deopujari, J and Charpentier, C. (1999) Occurrence of resveratrol and pterostilbene in age-old darakchasava, an ayurvedic medicine from India J Ethnopharmacol, 68, pp. 71-76.
3. Gehm, BD and Mcandrews, JM and Chien, PY and Jameson, JL. (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor Proc Natl Acad Sci USA, 94, pp. 14138-14143.
4. Bertelli, AAE and Giovannini, L and Bernini, W and Migliori, M and Fregoni, M and Bavaresco, L and Bertelli, A. (1996) Antiplatelet activity of cis-resveratrol Drugs Exp Clin Res, 22, pp. 61-63.
5. Pace-Asciak, CR and Hahn, S and Diamandis, EP and Soleas, G and Goldberg, DM. (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease Clin Chim Acta, 235, pp. 207-219.
6. Das, S and Bertelli, AA and Bertelli, A and Maulik, N and Das, DK.Antiinflammatory action of resveratrol: A novel mechanism of action Drugs Exp Clin Res. in press
7. Das, S and Tosaki, A and Bagchi, D and Maulik, N and Das, DK. (2005) Resveratrol-mediated activation of cAMP response element-binding protein through adenosine A3 receptor by Akt-dependent and -independent pathways J Pharmacol Exp Ther, 314, pp. 762-769.
8. Giovannini, L and Migliori, M and Longoni, BM and Das, DK and Bertelli, AA and Panichi, V and Filippi, C and Bertelli, A. (2001) Resveratrol, a polyphenol found in wine, reduces ischemia reperfusion injury in rat kidneys J Cardiovasc Pharmacol, 37, pp. 262-270.
9. Huang, SS and Tsai, MC and Chih, CL and Hung, LM and Tsai, SK. (2001) Resveratrol reduction of infarct size in long-evans rats subjected to focal cerebral ischemia Life Sci, 69, pp. 1057-1065.
10. Ray, PS and Maulik, G and Cordis, GA and Bertelli, AAE and Bertelli, A and Das, DK. (1999) The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury Free Radic Biol Med, 27, pp. 160-169.
11. Hattori, R and Otani, H and Maulik, N and Das, DK. (2002) Pharmacological preconditioning with resveratrol: Role of nitric oxide Am J Physiol, 282, pp. H1988-H1995.
12. Das, S and Alagappan, VK and Bagchi, D and Sharma, HS and Maulik, N and Das, DK. (2005) Coordinated induction of iNOS-VEGF-KDR-eNOS after resveratrol consumption: A potential mechanism for resveratrol preconditioning of the heart Vascul Pharmacol, 42, pp. 281-289.
13. Das, S and Cordis, GA and Maulik, N and Das, DK. (2005) Pharmacological preconditioning with resveratrol: A role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation Am J Physiol, 288, pp. H328-H335.
14. Choi, AMK. (2001) Heme oxygenase-1 protects the heart Circ Res, 89, pp. 105-107.
15. Lee, PJ and Jiang, BH and Chin, BY and Iyer, NV and Alam, J and Semenza, GL and Choi, AMK. (1997) Hypoxiainducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia J Biol Chem, 272, pp. 5375-5381.
16. Otterbein, LE and Lee, PJ and Chin, BY and Petrache, I and Camhi, SL and Alam, J and Choi, AM. (1999) Protective effects of heme oxygenase-1 in acute lung injury Chest, 116, pp. S61-S63.
17. Reeve, VE and Tyrrell, RM. (1999) Heme oxygenase induction mediates the photoimmunoprotective activity of UVA radiation in the mouse Proc Natl Acad Sci USA, 96, pp. 9317-9321.
18. Yet, SF and Tian, R and Layne, MD and Wang, ZY and Maemura, K and Solovyeva, M and Ith, B and Melo, LG and Zhang, L and Ingwall, JS and Dzau, VJ and Lee, ME and Perrella, MA. (2001) Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice Circ Res, 89, pp. 168-173.
19. Shibahara, S. (2003) The heme oxygenase dilemma in cellular homeostasis: New insights for the feedback regulation of heme catabolism Tohoku J Exp Med, 200, pp. 167-186.
20. Han, F and Takeda, K and Yokoyama, S and Ueda, H and Shinozawa, Y and Furuyama, K and Shibahara, S. (2005) Dynamic changes in expression of heme oxygenases in mouse heart and liver during hypoxia Biochem Biophys Res Commun, 338, pp. 653-659.
21. Bak, I and Szendrei, L and Turoczi, T and Papp, G and Joo, F and Das, DK and de Leiris, J and Der, P and Juhasz, B and Varga, E and Bacskay, I and Balla, J and Kovacs, P and Tosaki, A. (2003) Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium FASEB J, 17, pp. 2133-2135.
22. Akamatsu, Y and Haga, M and Tyagi, S and Yamashita, K and Graca-Souza, AV and Ollinger, R and Czismadia, E and May, GA and Ifedigbo, E and Otterbein, LE and Bach, FH and Soares, MP. (2004) Heme oxygenase-1-derived carbon monoxide protects hearts from transplant associated ischemia reperfusion injury FASEB J, 18, pp. 771-772.
23. Ockaili, R and Natarajan, R and Salloum, F and Fisher, BJ and Jones, D and Fowler, AA, 3rd and Kukreja, RC. (2005) HIF-1 activation attenuates postischemic myocardial injury: Role for heme oxygenase-1 in modulating microvascular chemokine generation Am J Physiol Heart Circ Physiol, 289, pp. H542-H548.
24. Di Filippo, C and Marfella, R and Cuzzocrea, S and Piegari, E and Petronella, P and Giugliano, D and Rossi, F and D'Amico, M. (2005) Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/ reperfusion Diabetes, 54, pp. 803-810.
25. Liu, X and Wei, J and Peng, DH and Layne, MD and Yet, SF. (2005) Absence of heme oxygenase-1 exacerbates myocardial ischemia/reperfusion injury in diabetic mice Diabetes, 54, pp. 778-784.
26. Tongers, J and Fiedler, B and Konig, D and Kempf, T and Klein, G and Heineke, J and Kraft, T and Gambaryan, S and Lohmann, SM and Drexler, H and Wollert, KC. (2004) Heme oxygenase-1 inhibition of MAP kinases, calcineurin/NFAT signaling, and hypertrophy in cardiac myocytes Cardiovasc Res, 63, pp. 545-552.
27. Perrella, MA and Yet, SF. (2003) Role of heme oxygenase-1 in cardiovascular function Curr Pharm Des, 9, pp. 2479-2487.
28. Chen, YH and Yet, SF and Perrella, MA. (2003) Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function Exp Biol Med (Maywood), 228, pp. 447-453.
29. Vulapalli, SR and Chen, Z and Chua, BH and Wang, T and Liang, CS. (2002) Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis Am J Physiol Heart Circ Physiol, 283, pp. H688-H694.
30. Melo, LG and Agrawal, R and Zhang, L and Rezvani, M and Mangi, AA and Ehsan, A and Griese, DP and Dell'Acqua, G and Mann, MJ and Oyama, J and Yet, SF and Layne, MD and Perrella, MA and Dzau, VJ. (2002) Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene Circulation, 105, pp. 602-607.
31. Maulik, N and Engelman, DT and Watanabe, M and Engelman, RM and Maulik, G and Cordis, GA and Das, DK. (1995) Nitric oxide signaling in ischemic heart Cardiovasc Res, 30, pp. 593-601.
32. Tang, XL and Takano, H and Xuan, YT and Sato, H and Kodani, E and Dawn, B and Zhu, Y and Shirk, G and Wu, WJ and Bolli, R. (2005) Hypercholesterolemia abrogates late preconditioning via a tetrahydrobiopterin-dependent mechanism in conscious rabbits Circulation, 112, pp. 2149-2156.
33. Li, Q and Guo, Y and Tan, W and Stein, AB and Dawn, B and Wu, WJ and Zhu, X and Lu, X and Xu, X and Siddiqui, T and Tiwari, S and Bolli, R. (2005) Gene therapy with iNOS provides long-term protection against myocardial infarction without adverse functional consequences Am J Physiol Heart Circ Physiol, 290, pp. H584-H589.
34. Kupatt, C and Hinkel, R and Lamparter, M and von Bruhl, ML and Pohl, T and Horstkotte, J and Beck, H and Muller, S and Delker, S and Gildehaus, FJ and Buning, H and Hatzopoulos, AK and Boekstegers, P. (2005) Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: Role of phosphatidylinositol 3-kinase/AKT kinase Circulation, 112, pp. I117-I122.
35. Datta, PK and Dhupar, S and Lianos, EA. (2006) Regulatory effects of inducible nitric oxide synthase on cyclooxygenase-2 and heme oxygenase-1 expression in experimental glomerulonephritis Nephrol Dial Transplant, 21, pp. 51-57.
36. Reiter, TA and Demple, B. (2005) Carbon monoxide mediates protection against nitric oxide toxicity in HeLa cells Free Radic Biol Med, 39, pp. 1075-1088.
37. Juan, SH and Cheng, TH and Lin, HC and Chu, YL and Lee, WS. (2005) Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells Biochem Pharmacol, 69, pp. 41-48.
38. Huang, HM and Liang, YC and Cheng, TH and Chen, CH and Juan, SH. (2005) Potential mechanism of blood vessel protection by resveratrol, a component of red wine Ann N Y Acad Sci, 1042, pp. 349-356.
39. Maulik, N and Goswami, S and Galang, N and Das, DK. (1999) Differential regulation of Bcl-2, AP-1, NFkB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation FEBS Lett, 443, pp. 331-336.
40. Garthwaite, J and Boulton, CL. (1995) Nitric oxide signaling in the central nervous system Annu Rev Physiol, 57, pp. 683-706.
41. Zhuang, H and Kim, YS and Koehler, RC and Dore, S. (2003) Potential mechanism by which resveratrol, a red wine constituent, protects neurons Ann N Y Acad Sci, 993, pp. 276-286.
42. Scapagnini, G and Butterfield, DA and Colombrita, C and Sultana, R and Pascale, A and Calabrese, V. (2004) Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress Antioxid Redox Signal, 6, pp. 811-818.
43. Juan, SH and Cheng, TH and Lin, HC and Chu, YL and Lee, WS. (2005) Mechanism of concentration-dependent induction of heme oxygenase-1 by resveratrol in human aortic smooth muscle cells Biochem Pharmacol, 69, pp. 41-48.
44. Chen, CY and Jang, JH and Li, MH and Surh, YJ. (2005) Resveratrol upregulates heme oxygenase-1 expression via activation of NF-E2-related factor 2 in PC12 cells Biochem Biophys Res Commun, 331, pp. 993-1000.
45. Dore, S. (2005) Unique properties of polyphenol stilbenes in the brain: More than direct antioxidant actions; gene/protein regulatory activity NeuroSignals, 14, pp. 61-70.
46. Wung, BS and Hsu, MC and Wu, CC and Hsieh, CW. (2006) Piceatannol upregulates endothelial heme oxygenase-1 expression via novel protein kinase C and tyrosine kinase pathways Pharmacol Res, 53, pp. 113-122.
47. Maulik, N and Sato, M and Price, BD and Das, DK. (1998) An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia FEBS Lett, 429, pp. 365-369.
48. Armstrong, SC and Delacey, M and Ganote, CE. (1999) Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes J Mol Cell Cardiol, 31, pp. 555-567.
49. Schulz, R and Belosjorow, S and Gres, P and Jansen, J and Michel, MC and Heusch, G. (2002) p38 MAP kinase is a mediator of ischemic preconditioning in pigs Cardiovasc Res, 55, pp. 690-700.